Search Results

This fact sheet is a step-by-step guideline discussing the supplies required, limitations and precautions, pharmacokinetics, proper storage, and accurate placement for injection of Amikacin with picture guides. The reverse side features a table covering Amikacin, Streptomycin, and Capreomycin...

The Stop TB poster can be used by TB programs and other healthcare settings to help educate people with TB, as well as people at risk for TB. The poster describes how TB is spread, explains the difference between latent TB infection and TB disease, includes symptoms of active TB disease, and...

The Stop TB poster can be used by TB programs and other healthcare settings to help educate people with TB, as well as people at risk for TB. The poster describes how TB is spread, explains the difference between latent TB infection and TB disease, includes symptoms of active TB disease, and...

This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.

This material was developed for clinicians to use with patients that are prescribed the three months of daily isoniazid plus rifampin (3HR) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There...

This material was developed for clinicians to use with patients that are prescribed the 12-dose regimen for the treatment of latent TB infection. There is space to write treatment schedules, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms...

The patient education brochure was developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events.

The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. English is on one side and Ukrainian is on the other.

This report is the annual compilation of data from World Health Organization’s (WHO) 193 member states. It provides a summary of the current status of national health and health systems, including mortality and burden of disease, causes of death, reported infectious diseases, health service coverage...

This document informs national TB programs and stakeholders about the key implications for the treatment of drug-resistant tuberculosis. This resource is available before the release of the updated guidelines in order for planning at the country level. The guidelines are expected to be released in...